Share Price and Basic Stock Data
Last Updated: January 12, 2026, 4:02 pm
| PEG Ratio | 1.32 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Continental Seeds and Chemicals Ltd operates in the seeds, tissue culture, and biotechnology industry, with its current market capitalization standing at ₹28.8 Cr. The company’s share price is ₹21.0, reflecting a Price-to-Earnings (P/E) ratio of 37.4, indicating a premium valuation compared to typical sector averages. Over the past few years, revenue trends have shown fluctuations; for instance, sales for the fiscal year ending March 2024 reported ₹97.68 Cr, while the trailing twelve months (TTM) sales stood at ₹67.79 Cr. The quarterly sales figures indicate a recovery trend, with the most recent quarter (September 2023) recording sales of ₹39.24 Cr, up from ₹38.33 Cr in the same quarter a year prior. However, this is a decline from the ₹57.07 Cr recorded in September 2021. The company’s operational performance is characterized by a high operating profit margin (OPM) of 8.85% as of September 2025, suggesting an improvement in cost management and operational efficiency.
Profitability and Efficiency Metrics
Continental Seeds has demonstrated varying profitability metrics over the years. The net profit for the fiscal year ending March 2025 rose to ₹1.83 Cr, compared to just ₹0.02 Cr in March 2023, highlighting a significant turnaround. This positive trend is complemented by an increase in earnings per share (EPS), which reached ₹1.44 for FY 2025, up from ₹0.67 in FY 2024. The operating profit for the same period was reported at ₹2.79 Cr, while the operating profit margin reflected an upward trajectory of 3.07%. Efficiency metrics also indicate a mixed performance; the Return on Equity (ROE) stood at a modest 2.87%, while the Return on Capital Employed (ROCE) was reported at 4.24%. The cash conversion cycle (CCC) of 64.99 days suggests that the company has improved its working capital management, although it still indicates room for further optimization compared to industry standards.
Balance Sheet Strength and Financial Ratios
The financial health of Continental Seeds is supported by a stable balance sheet, with total assets amounting to ₹36.62 Cr as of March 2025, up from ₹26.54 Cr the previous year. The company reported total borrowings of ₹3.72 Cr, indicating a low leverage position with a debt-to-equity ratio of 0.11, which is favorable compared to sector norms. Reserves have significantly increased to ₹16.46 Cr as of September 2025, reflecting retained earnings and strengthening the equity base. Key financial ratios also show improvement; the interest coverage ratio (ICR) stood at 8.99, suggesting that the company can comfortably meet its interest obligations. The current ratio is reported at 2.82, indicating a strong liquidity position. However, the Price-to-Book Value (P/BV) ratio of 1.30x suggests that the stock is trading at a premium relative to its book value, which may be a point of concern for value investors.
Shareholding Pattern and Investor Confidence
The shareholding structure of Continental Seeds indicates a strong promoter holding of 60.06% as of October 2025, which may instill confidence among investors regarding the company’s governance and strategic direction. Foreign Institutional Investors (FIIs) hold 12.41%, marking a significant increase from previous quarters where their stake was negligible. The public holding stands at 27.54%, showing a moderate level of retail participation in the company. The total number of shareholders has grown to 371, which reflects increasing interest in the stock. However, the declining promoter share from 72.27% in September 2022 to the current level may raise concerns about potential dilution. This shift could be interpreted as an effort to attract more institutional investors, but it also poses a risk if it leads to instability in share price performance.
Outlook, Risks, and Final Insight
Looking ahead, Continental Seeds faces both opportunities and challenges. The positive trajectory in profitability metrics is a strong indicator of potential growth, particularly as the company enhances its operational efficiencies. However, risks remain, including the volatility in sales, which can impact cash flows and profitability. The reliance on external financing, despite a low debt level, may become a concern if interest rates rise or market conditions worsen. Additionally, the changing shareholding structure could affect investor sentiment if perceived negatively. The company’s ability to maintain its operational improvements while navigating these risks will be crucial for its future performance. Ultimately, while the fundamentals show promise, maintaining a close watch on market dynamics and internal efficiencies will be essential for sustained growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Genomic Valley Biotech Ltd | 7.61 Cr. | 24.9 | 70.9/21.0 | 12.8 | 0.00 % | 11.8 % | 9.69 % | 10.0 | |
| Genesis IBRC India Ltd | 101 Cr. | 78.0 | 185/17.5 | 6.42 | 0.00 % | 51.6 % | 51.6 % | 10.0 | |
| Shreeoswal Seeds & Chemicals Ltd | 137 Cr. | 15.0 | 20.3/10.7 | 13.7 | 5.23 | 0.00 % | 9.88 % | 8.41 % | 2.00 |
| Nath Bio-Genes (India) Ltd | 281 Cr. | 148 | 239/138 | 5.96 | 362 | 1.35 % | 7.35 % | 6.77 % | 10.0 |
| Continental Seeds and Chemicals Ltd | 28.8 Cr. | 21.0 | 34.8/19.3 | 37.4 | 22.5 | 0.00 % | 4.24 % | 2.87 % | 10.0 |
| Industry Average | 173.00 Cr | 57.38 | 19.02 | 81.79 | 0.27% | 16.97% | 15.87% | 8.40 |
All Competitor Stocks of Continental Seeds and Chemicals Ltd
Quarterly Result
| Metric | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Sep 2022 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25.27 | 62.65 | 38.33 | 57.07 | 38.33 | 57.07 | 39.24 | 58.44 | 43.53 | 47.22 | 20.57 |
| Expenses | 24.72 | 61.78 | 37.65 | 56.36 | 37.65 | 56.36 | 37.57 | 60.18 | 42.16 | 45.80 | 18.75 |
| Operating Profit | 0.55 | 0.87 | 0.68 | 0.71 | 0.68 | 0.71 | 1.67 | -1.74 | 1.37 | 1.42 | 1.82 |
| OPM % | 2.18% | 1.39% | 1.77% | 1.24% | 1.77% | 1.24% | 4.26% | -2.98% | 3.15% | 3.01% | 8.85% |
| Other Income | 0.12 | 0.19 | 0.13 | 0.12 | 0.13 | 0.12 | 0.16 | 4.21 | 1.65 | 0.66 | 0.15 |
| Interest | 0.22 | 0.21 | 0.24 | 0.30 | 0.24 | 0.30 | 0.24 | 0.29 | 0.22 | 0.18 | 0.18 |
| Depreciation | 0.25 | 0.19 | 0.22 | 0.39 | 0.22 | 0.39 | 1.47 | 1.50 | 1.29 | 1.20 | 1.36 |
| Profit before tax | 0.20 | 0.66 | 0.35 | 0.14 | 0.35 | 0.14 | 0.12 | 0.68 | 1.51 | 0.70 | 0.43 |
| Tax % | 90.00% | 3.03% | 31.43% | 0.00% | 31.43% | 0.00% | -8.33% | 20.59% | 22.52% | 4.29% | 55.81% |
| Net Profit | 0.01 | 0.63 | 0.23 | 0.14 | 0.23 | 0.14 | 0.12 | 0.54 | 1.17 | 0.66 | 0.19 |
| EPS in Rs | 0.01 | 0.63 | 0.23 | 0.14 | 0.23 | 0.14 | 0.12 | 0.54 | 1.06 | 0.52 | 0.14 |
Last Updated: January 2, 2026, 1:37 am
Below is a detailed analysis of the quarterly data for Continental Seeds and Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 20.57 Cr.. The value appears to be declining and may need further review. It has decreased from 47.22 Cr. (Mar 2025) to 20.57 Cr., marking a decrease of 26.65 Cr..
- For Expenses, as of Sep 2025, the value is 18.75 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 45.80 Cr. (Mar 2025) to 18.75 Cr., marking a decrease of 27.05 Cr..
- For Operating Profit, as of Sep 2025, the value is 1.82 Cr.. The value appears strong and on an upward trend. It has increased from 1.42 Cr. (Mar 2025) to 1.82 Cr., marking an increase of 0.40 Cr..
- For OPM %, as of Sep 2025, the value is 8.85%. The value appears strong and on an upward trend. It has increased from 3.01% (Mar 2025) to 8.85%, marking an increase of 5.84%.
- For Other Income, as of Sep 2025, the value is 0.15 Cr.. The value appears to be declining and may need further review. It has decreased from 0.66 Cr. (Mar 2025) to 0.15 Cr., marking a decrease of 0.51 Cr..
- For Interest, as of Sep 2025, the value is 0.18 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.18 Cr..
- For Depreciation, as of Sep 2025, the value is 1.36 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.20 Cr. (Mar 2025) to 1.36 Cr., marking an increase of 0.16 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.43 Cr.. The value appears to be declining and may need further review. It has decreased from 0.70 Cr. (Mar 2025) to 0.43 Cr., marking a decrease of 0.27 Cr..
- For Tax %, as of Sep 2025, the value is 55.81%. The value appears to be increasing, which may not be favorable. It has increased from 4.29% (Mar 2025) to 55.81%, marking an increase of 51.52%.
- For Net Profit, as of Sep 2025, the value is 0.19 Cr.. The value appears to be declining and may need further review. It has decreased from 0.66 Cr. (Mar 2025) to 0.19 Cr., marking a decrease of 0.47 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.14. The value appears to be declining and may need further review. It has decreased from 0.52 (Mar 2025) to 0.14, marking a decrease of 0.38.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:29 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 54.56 | 57.69 | 58.07 | 58.19 | 81.62 | 82.10 | 87.68 | 95.36 | 97.88 | 75.41 | 97.68 | 90.75 | 67.79 |
| Expenses | 54.49 | 56.80 | 57.28 | 56.71 | 79.77 | 80.37 | 86.24 | 93.88 | 96.10 | 71.50 | 97.74 | 87.96 | 64.55 |
| Operating Profit | 0.07 | 0.89 | 0.79 | 1.48 | 1.85 | 1.73 | 1.44 | 1.48 | 1.78 | 3.91 | -0.06 | 2.79 | 3.24 |
| OPM % | 0.13% | 1.54% | 1.36% | 2.54% | 2.27% | 2.11% | 1.64% | 1.55% | 1.82% | 5.18% | -0.06% | 3.07% | 4.78% |
| Other Income | 0.30 | 0.09 | 0.06 | 0.05 | 0.09 | 0.10 | 0.31 | 0.26 | 0.24 | 0.16 | 4.37 | 2.30 | 0.81 |
| Interest | 0.00 | 0.36 | 0.52 | 0.62 | 0.62 | 0.70 | 0.45 | 0.64 | 0.39 | 0.53 | 0.54 | 0.40 | 0.36 |
| Depreciation | 0.08 | 0.24 | 0.10 | 0.20 | 0.26 | 0.27 | 0.44 | 0.61 | 1.25 | 3.52 | 2.97 | 2.49 | 2.56 |
| Profit before tax | 0.29 | 0.38 | 0.23 | 0.71 | 1.06 | 0.86 | 0.86 | 0.49 | 0.38 | 0.02 | 0.80 | 2.20 | 1.13 |
| Tax % | 27.59% | 31.58% | 26.09% | 33.80% | 32.08% | 45.35% | 25.58% | 22.45% | 47.37% | 50.00% | 16.25% | 16.82% | |
| Net Profit | 0.22 | 0.27 | 0.16 | 0.47 | 0.72 | 0.46 | 0.65 | 0.37 | 0.19 | 0.02 | 0.67 | 1.83 | 0.85 |
| EPS in Rs | 1.05 | 1.29 | 0.76 | 2.24 | 0.72 | 0.46 | 0.65 | 0.37 | 0.19 | 0.02 | 0.67 | 1.44 | 0.66 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 22.73% | -40.74% | 193.75% | 53.19% | -36.11% | 41.30% | -43.08% | -48.65% | -89.47% | 3250.00% | 173.13% |
| Change in YoY Net Profit Growth (%) | 0.00% | -63.47% | 234.49% | -140.56% | -89.30% | 77.42% | -84.38% | -5.57% | -40.83% | 3339.47% | -3076.87% |
Continental Seeds and Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 1% |
| 3 Years: | -2% |
| TTM: | -7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 0% |
| 3 Years: | 41% |
| TTM: | 126% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 20% |
| 3 Years: | 40% |
| 1 Year: | -64% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | -2% |
| 3 Years: | -4% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 2:15 am
Balance Sheet
Last Updated: December 4, 2025, 1:07 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.25 | 1.25 | 1.25 | 1.25 | 6.00 | 6.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 12.70 | 13.20 |
| Reserves | 3.50 | 3.76 | 3.92 | 4.41 | 4.59 | 5.03 | 1.68 | 2.03 | 2.23 | 2.30 | 2.69 | 15.68 | 16.46 |
| Borrowings | 0.00 | 2.59 | 4.01 | 4.63 | 3.75 | 3.68 | 4.75 | 7.62 | 5.65 | 6.17 | 5.45 | 3.91 | 3.72 |
| Other Liabilities | 0.68 | 1.61 | 3.03 | 2.38 | 22.11 | 14.10 | 5.89 | 13.77 | 13.77 | 12.24 | 8.40 | 4.33 | 5.24 |
| Total Liabilities | 5.43 | 9.21 | 12.21 | 12.67 | 36.45 | 28.81 | 22.32 | 33.42 | 31.65 | 30.71 | 26.54 | 36.62 | 38.62 |
| Fixed Assets | 0.73 | 0.50 | 0.40 | 1.56 | 1.31 | 1.67 | 3.15 | 4.55 | 20.80 | 18.18 | 15.66 | 15.29 | 14.97 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.41 | 4.73 | 11.82 | 0.00 | 0.00 | 0.49 | 0.00 | 1.17 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 4.70 | 8.71 | 11.81 | 11.11 | 35.14 | 25.73 | 14.44 | 17.05 | 10.85 | 12.53 | 10.39 | 21.33 | 22.48 |
| Total Assets | 5.43 | 9.21 | 12.21 | 12.67 | 36.45 | 28.81 | 22.32 | 33.42 | 31.65 | 30.71 | 26.54 | 36.62 | 38.62 |
Below is a detailed analysis of the balance sheet data for Continental Seeds and Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.20 Cr.. The value appears strong and on an upward trend. It has increased from 12.70 Cr. (Mar 2025) to 13.20 Cr., marking an increase of 0.50 Cr..
- For Reserves, as of Sep 2025, the value is 16.46 Cr.. The value appears strong and on an upward trend. It has increased from 15.68 Cr. (Mar 2025) to 16.46 Cr., marking an increase of 0.78 Cr..
- For Borrowings, as of Sep 2025, the value is 3.72 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 3.91 Cr. (Mar 2025) to 3.72 Cr., marking a decrease of 0.19 Cr..
- For Other Liabilities, as of Sep 2025, the value is 5.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.33 Cr. (Mar 2025) to 5.24 Cr., marking an increase of 0.91 Cr..
- For Total Liabilities, as of Sep 2025, the value is 38.62 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 36.62 Cr. (Mar 2025) to 38.62 Cr., marking an increase of 2.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 14.97 Cr.. The value appears to be declining and may need further review. It has decreased from 15.29 Cr. (Mar 2025) to 14.97 Cr., marking a decrease of 0.32 Cr..
- For CWIP, as of Sep 2025, the value is 1.17 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.17 Cr., marking an increase of 1.17 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 22.48 Cr.. The value appears strong and on an upward trend. It has increased from 21.33 Cr. (Mar 2025) to 22.48 Cr., marking an increase of 1.15 Cr..
- For Total Assets, as of Sep 2025, the value is 38.62 Cr.. The value appears strong and on an upward trend. It has increased from 36.62 Cr. (Mar 2025) to 38.62 Cr., marking an increase of 2.00 Cr..
Notably, the Reserves (16.46 Cr.) exceed the Borrowings (3.72 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.07 | -1.70 | -3.22 | -3.15 | -1.90 | -1.95 | -3.31 | -6.14 | -3.87 | -2.26 | -5.51 | -1.12 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 4.95 | 9.55 | 42.68 | 37.89 | 111.80 | 57.26 | 13.28 | 33.87 | 9.14 | 17.81 | 12.74 | 24.45 |
| Inventory Days | 1.97 | 32.35 | 19.39 | 21.47 | 16.45 | 16.50 | 21.19 | 21.95 | 23.75 | 16.75 | 13.09 | 45.72 |
| Days Payable | 0.07 | 5.34 | 13.72 | 0.13 | 95.65 | 59.47 | 12.83 | 33.71 | 73.24 | 33.22 | 9.56 | 5.19 |
| Cash Conversion Cycle | 6.85 | 36.57 | 48.35 | 59.23 | 32.60 | 14.29 | 21.63 | 22.11 | -40.36 | 1.34 | 16.27 | 64.99 |
| Working Capital Days | 13.31 | 37.52 | 33.25 | 34.56 | 22.14 | 10.94 | 9.57 | -14.20 | -34.31 | -7.31 | -4.07 | 48.67 |
| ROCE % | 6.25% | 11.98% | 8.94% | 13.76% | 13.64% | 10.95% | 7.77% | 6.54% | 4.26% | 3.30% | -10.00% | 4.24% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.44 | 0.67 | 0.02 | 0.19 | 0.37 |
| Diluted EPS (Rs.) | 1.44 | 0.67 | 0.02 | 0.19 | 0.37 |
| Cash EPS (Rs.) | 3.40 | 3.64 | 3.54 | 1.44 | 0.98 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 22.34 | 12.69 | 12.30 | 12.23 | 12.03 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 22.34 | 12.69 | 12.30 | 12.23 | 12.03 |
| Revenue From Operations / Share (Rs.) | 71.44 | 97.65 | 75.39 | 97.86 | 95.37 |
| PBDIT / Share (Rs.) | 2.80 | 1.13 | 4.12 | 2.04 | 1.69 |
| PBIT / Share (Rs.) | 0.83 | -1.84 | 0.60 | 0.79 | 1.08 |
| PBT / Share (Rs.) | 1.73 | 0.79 | 0.02 | 0.37 | 0.48 |
| Net Profit / Share (Rs.) | 1.44 | 0.66 | 0.01 | 0.18 | 0.37 |
| PBDIT Margin (%) | 3.92 | 1.15 | 5.46 | 2.08 | 1.77 |
| PBIT Margin (%) | 1.17 | -1.88 | 0.79 | 0.81 | 1.12 |
| PBT Margin (%) | 2.42 | 0.81 | 0.02 | 0.38 | 0.51 |
| Net Profit Margin (%) | 2.01 | 0.68 | 0.02 | 0.19 | 0.39 |
| Return on Networth / Equity (%) | 6.43 | 5.24 | 0.13 | 1.52 | 3.11 |
| Return on Capital Employeed (%) | 3.56 | -10.48 | 3.14 | 5.40 | 6.85 |
| Return On Assets (%) | 4.98 | 2.51 | 0.05 | 0.59 | 1.12 |
| Long Term Debt / Equity (X) | 0.01 | 0.13 | 0.22 | 0.19 | 0.29 |
| Total Debt / Equity (X) | 0.11 | 0.36 | 0.44 | 0.41 | 0.55 |
| Asset Turnover Ratio (%) | 2.87 | 3.41 | 2.42 | 3.01 | 3.42 |
| Current Ratio (X) | 2.82 | 0.88 | 0.87 | 0.50 | 0.84 |
| Quick Ratio (X) | 1.35 | 0.53 | 0.62 | 0.29 | 0.65 |
| Inventory Turnover Ratio (X) | 13.94 | 2.63 | 0.99 | 9.28 | 7.42 |
| Interest Coverage Ratio (X) | 8.99 | 2.12 | 7.75 | 5.32 | 3.12 |
| Interest Coverage Ratio (Post Tax) (X) | 1.75 | -3.69 | 1.12 | 1.58 | 1.78 |
| Enterprise Value (Cr.) | 40.05 | 27.54 | 18.24 | 14.60 | 12.26 |
| EV / Net Operating Revenue (X) | 0.44 | 0.28 | 0.24 | 0.14 | 0.12 |
| EV / EBITDA (X) | 11.25 | 24.31 | 4.43 | 7.14 | 7.25 |
| MarketCap / Net Operating Revenue (X) | 0.40 | 0.23 | 0.16 | 0.10 | 0.06 |
| Price / BV (X) | 1.30 | 1.81 | 1.04 | 0.84 | 0.49 |
| Price / Net Operating Revenue (X) | 0.40 | 0.23 | 0.16 | 0.10 | 0.06 |
| EarningsYield | 0.04 | 0.02 | 0.00 | 0.01 | 0.06 |
After reviewing the key financial ratios for Continental Seeds and Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 5. It has increased from 0.67 (Mar 24) to 1.44, marking an increase of 0.77.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 5. It has increased from 0.67 (Mar 24) to 1.44, marking an increase of 0.77.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.40. This value is within the healthy range. It has decreased from 3.64 (Mar 24) to 3.40, marking a decrease of 0.24.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.34. It has increased from 12.69 (Mar 24) to 22.34, marking an increase of 9.65.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.34. It has increased from 12.69 (Mar 24) to 22.34, marking an increase of 9.65.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 71.44. It has decreased from 97.65 (Mar 24) to 71.44, marking a decrease of 26.21.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.80. This value is within the healthy range. It has increased from 1.13 (Mar 24) to 2.80, marking an increase of 1.67.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.83. This value is within the healthy range. It has increased from -1.84 (Mar 24) to 0.83, marking an increase of 2.67.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 0.79 (Mar 24) to 1.73, marking an increase of 0.94.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 2. It has increased from 0.66 (Mar 24) to 1.44, marking an increase of 0.78.
- For PBDIT Margin (%), as of Mar 25, the value is 3.92. This value is below the healthy minimum of 10. It has increased from 1.15 (Mar 24) to 3.92, marking an increase of 2.77.
- For PBIT Margin (%), as of Mar 25, the value is 1.17. This value is below the healthy minimum of 10. It has increased from -1.88 (Mar 24) to 1.17, marking an increase of 3.05.
- For PBT Margin (%), as of Mar 25, the value is 2.42. This value is below the healthy minimum of 10. It has increased from 0.81 (Mar 24) to 2.42, marking an increase of 1.61.
- For Net Profit Margin (%), as of Mar 25, the value is 2.01. This value is below the healthy minimum of 5. It has increased from 0.68 (Mar 24) to 2.01, marking an increase of 1.33.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.43. This value is below the healthy minimum of 15. It has increased from 5.24 (Mar 24) to 6.43, marking an increase of 1.19.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.56. This value is below the healthy minimum of 10. It has increased from -10.48 (Mar 24) to 3.56, marking an increase of 14.04.
- For Return On Assets (%), as of Mar 25, the value is 4.98. This value is below the healthy minimum of 5. It has increased from 2.51 (Mar 24) to 4.98, marking an increase of 2.47.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.13 (Mar 24) to 0.01, marking a decrease of 0.12.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.11. This value is within the healthy range. It has decreased from 0.36 (Mar 24) to 0.11, marking a decrease of 0.25.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.87. It has decreased from 3.41 (Mar 24) to 2.87, marking a decrease of 0.54.
- For Current Ratio (X), as of Mar 25, the value is 2.82. This value is within the healthy range. It has increased from 0.88 (Mar 24) to 2.82, marking an increase of 1.94.
- For Quick Ratio (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has increased from 0.53 (Mar 24) to 1.35, marking an increase of 0.82.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 13.94. This value exceeds the healthy maximum of 8. It has increased from 2.63 (Mar 24) to 13.94, marking an increase of 11.31.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.99. This value is within the healthy range. It has increased from 2.12 (Mar 24) to 8.99, marking an increase of 6.87.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.75. This value is below the healthy minimum of 3. It has increased from -3.69 (Mar 24) to 1.75, marking an increase of 5.44.
- For Enterprise Value (Cr.), as of Mar 25, the value is 40.05. It has increased from 27.54 (Mar 24) to 40.05, marking an increase of 12.51.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has increased from 0.28 (Mar 24) to 0.44, marking an increase of 0.16.
- For EV / EBITDA (X), as of Mar 25, the value is 11.25. This value is within the healthy range. It has decreased from 24.31 (Mar 24) to 11.25, marking a decrease of 13.06.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 24) to 0.40, marking an increase of 0.17.
- For Price / BV (X), as of Mar 25, the value is 1.30. This value is within the healthy range. It has decreased from 1.81 (Mar 24) to 1.30, marking a decrease of 0.51.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 24) to 0.40, marking an increase of 0.17.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.04, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Continental Seeds and Chemicals Ltd:
- Net Profit Margin: 2.01%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.56% (Industry Average ROCE: 16.97%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.43% (Industry Average ROE: 15.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.35
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 37.4 (Industry average Stock P/E: 19.02)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.11
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.01%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Seeds/Tissue Culture/Bio Technology | DTJ-114, DLF Tower B, Jasola, New Delhi Delhi 110025 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pravin Rastogi | Chairman & Managing Director |
| Mrs. Nidhi Gupta | Executive & Women Director |
| Mr. Sachin Rastogi | Executive Director |
| Mr. Prashant Rastogi | Independent Director |
| Mr. Gopal Krishan Sharma | Independent Director |
| Mr. Vivek Kumar Mathur | Independent Director |
FAQ
What is the intrinsic value of Continental Seeds and Chemicals Ltd?
Continental Seeds and Chemicals Ltd's intrinsic value (as of 17 January 2026) is ₹25.28 which is 20.38% higher the current market price of ₹21.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹28.8 Cr. market cap, FY2025-2026 high/low of ₹34.8/19.3, reserves of ₹16.46 Cr, and liabilities of ₹38.62 Cr.
What is the Market Cap of Continental Seeds and Chemicals Ltd?
The Market Cap of Continental Seeds and Chemicals Ltd is 28.8 Cr..
What is the current Stock Price of Continental Seeds and Chemicals Ltd as on 17 January 2026?
The current stock price of Continental Seeds and Chemicals Ltd as on 17 January 2026 is ₹21.0.
What is the High / Low of Continental Seeds and Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Continental Seeds and Chemicals Ltd stocks is ₹34.8/19.3.
What is the Stock P/E of Continental Seeds and Chemicals Ltd?
The Stock P/E of Continental Seeds and Chemicals Ltd is 37.4.
What is the Book Value of Continental Seeds and Chemicals Ltd?
The Book Value of Continental Seeds and Chemicals Ltd is 22.5.
What is the Dividend Yield of Continental Seeds and Chemicals Ltd?
The Dividend Yield of Continental Seeds and Chemicals Ltd is 0.00 %.
What is the ROCE of Continental Seeds and Chemicals Ltd?
The ROCE of Continental Seeds and Chemicals Ltd is 4.24 %.
What is the ROE of Continental Seeds and Chemicals Ltd?
The ROE of Continental Seeds and Chemicals Ltd is 2.87 %.
What is the Face Value of Continental Seeds and Chemicals Ltd?
The Face Value of Continental Seeds and Chemicals Ltd is 10.0.